Back
Leggett & Platt Vs. Keros Therapeutics Industry Stock Comparison
Sell
22
LEG
Leggett & Platt
Last Price:
11.46
Seasonality Move:
0.62%
Sell
27
KROS
Keros Therapeutics
Last Price:
45.71
Seasonality Move:
-4.71%
Sell
22
Leggett & Platt (LEG)
is a Sell
Is Leggett & Platt a Buy, Sell or Hold?
- The current Leggett & Platt [LEG] share price is $11.46. The Score for LEG is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- LEG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LEG Stock Price Chart
What is Leggett & Platt's stock price today?
-
The Leggett & Platt share price today is $11.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEG is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
LEG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.44 | Sell |
Relative Strength Index (14 RSI): | 45.06 | Sell |
Chaikin Money Flow: | 3666156 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.85 - 12.09) | Sell |
Bollinger Bands (100): | (12.47 - 20.19) | Sell |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.79 | Sell |
Relative Strength Index (14 RSI): | 38.41 | Sell |
Chaikin Money Flow: | 239305 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.72 - 49.1) | Sell |
Bollinger Bands (100): | (49.87 - 64.91) | Sell |
LEG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.46 | Buy |
20-day SMA: | 11.68 | Sell |
50-day SMA: | 13.04 | Sell |
200-day SMA: | 20.45 | Sell |
8-day EMA: | 11.33 | Buy |
20-day EMA: | 11.63 | Sell |
50-day EMA: | 13.17 | Sell |
200-day EMA: | 19.64 | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.61 | Buy |
20-day SMA: | 47.29 | Sell |
50-day SMA: | 51.65 | Sell |
200-day SMA: | 47.07 | Sell |
8-day EMA: | 45.93 | Sell |
20-day EMA: | 47.34 | Sell |
50-day EMA: | 50.89 | Sell |
200-day EMA: | 50 | Sell |
Leggett & Platt Earnings Growth & LEG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.27 per share, and an increase next year of $0.17 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Leggett & Platt Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |